TY - BOOK
T1 - Securing the Future of Complementary Medicines Manufacturing in Australia: A Strategic Business Case
AU - NICM Health Research Institute, null
PY - 2023
Y1 - 2023
N2 - The $6 billion per annum complementary medicines manufacturing industry stands at a crucial crossroads: maintain the status quo or invest in catalysing industry growth by capturing greater market share of the rapidly expanding global market. Through extensive research\, analysis and consultation this report identifies various opportunities and challenges facing the industry and provides an evidence-based set of recommendations and associated business case. This report presents recommendations to government\, proposing a co-investment model that has the potential to support Australian manufacturers to triple industry revenues by 2032. The aim will be achieved through capturing a greater proportion of the global complementary medicine market\, fostering a skilled manufacturing workforce\, protecting sovereignty of supply and manufacture\, and fuelling job growth across Australia.
AB - The $6 billion per annum complementary medicines manufacturing industry stands at a crucial crossroads: maintain the status quo or invest in catalysing industry growth by capturing greater market share of the rapidly expanding global market. Through extensive research\, analysis and consultation this report identifies various opportunities and challenges facing the industry and provides an evidence-based set of recommendations and associated business case. This report presents recommendations to government\, proposing a co-investment model that has the potential to support Australian manufacturers to triple industry revenues by 2032. The aim will be achieved through capturing a greater proportion of the global complementary medicine market\, fostering a skilled manufacturing workforce\, protecting sovereignty of supply and manufacture\, and fuelling job growth across Australia.
UR - https://hdl.handle.net/1959.7/uws:73247
UR - https://westernsydney.edu.au/cmmanufacturing
U2 - 10.26183/kj2q-ee25
DO - 10.26183/kj2q-ee25
M3 - Research report
SN - 9781741085624
BT - Securing the Future of Complementary Medicines Manufacturing in Australia: A Strategic Business Case
PB - Western Sydney University
CY - Penrith\, N.S.W.
ER -
